Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.965
-0.165 (-5.27%)
At close: Feb 21, 2025, 4:00 PM
2.970
+0.005 (0.17%)
After-hours: Feb 21, 2025, 5:28 PM EST
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $378.32 million as of February 21, 2025. Its market cap has decreased by -39.59% in one year.
Market Cap
378.32M
Enterprise Value
244.04M
1-Year Change
-39.59%
Ranking
Category
Stock Price
$2.97
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $378.32M, a decrease of -76.75%. That is a compound annual growth rate of -46.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 378.32M | 1.54% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |